News articles

News article list

• NICE signs up to join the GetReal Institute

  NICE and the GetReal Institute: facilitating the adoption and implementation of real-world evidence in health care decision-making.

• Chemotherapy-free treatment option to be offered to patients with England’s most common leukaemia

  Acalabrutinib, taken as a twice daily tablet, is recommended as an option for adults with untreated chronic lymphocytic leukaemia.

• NICE provides access to new treatment option for advanced breast cancer

  NICE has today (20 April 2021) published draft guidance recommending trastuzumab deruxtecan for use in the Cancer Drugs Fund (CDF).

• NICE recommends range of treatments for people with chronic primary pain

  People with chronic primary pain should be offered a range of treatments to help them manage their condition.

• NICE publishes single guideline for managing COVID-19

  One year on from the first national lockdown, NICE has today (23 March) published a single guideline for the management of COVID-19 in children and adults.

• Ovarian cancer patients to have NICE-approved drug combination option on Cancer Drugs Fund

  A potentially life-extending drug combination for some people with advanced, high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer will now be available on the Cancer Drugs Fund (CDF), following its approval by NICE in draft guidance published today.